LFMDP vs VRTX · rev $212.5M vs P/E 30, rev $3.33B
LifeMD Inc Preferred Series A (LFMDP) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
LifeMD Inc Preferred Series A (LFMDP) is a health information services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported LFMDP revenue for 2024-12-31 was $212.5M. Net income was -$18.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. LFMDP currently screens at market cap $0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
LFMDP currently screens at market cap $0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the LFMDP and VRTX stock pages for the full models.
Not investment advice.